These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 21961650)

  • 1. Evidence for association of an ACCN1 gene variant with response to lithium treatment in Sardinian patients with bipolar disorder.
    Squassina A; Manchia M; Borg J; Congiu D; Costa M; Georgitsi M; Chillotti C; Ardau R; Mitropoulos K; Severino G; Del Zompo M; Patrinos GP
    Pharmacogenomics; 2011 Nov; 12(11):1559-69. PubMed ID: 21961650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenetics of lithium effects on glomerular function in bipolar disorder patients under chronic lithium treatment: a pilot study.
    Tsermpini EE; Zhang Y; Niola P; Chillotti C; Ardau R; Bocchetta A; Patrinos GP; Del Zompo M; Severino G; Lee MT; Squassina A
    Neurosci Lett; 2017 Jan; 638():1-4. PubMed ID: 27923663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin-like growth factor 1 (IGF-1) expression is up-regulated in lymphoblastoid cell lines of lithium responsive bipolar disorder patients.
    Squassina A; Costa M; Congiu D; Manchia M; Angius A; Deiana V; Ardau R; Chillotti C; Severino G; Calza S; Del Zompo M
    Pharmacol Res; 2013 Jul; 73():1-7. PubMed ID: 23619527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interacting genes in lithium prophylaxis: preliminary results of an exploratory analysis on the role of DGKH and NR1D1 gene polymorphisms in 199 Sardinian bipolar patients.
    Manchia M; Squassina A; Congiu D; Chillotti C; Ardau R; Severino G; Del Zompo M
    Neurosci Lett; 2009 Dec; 467(2):67-71. PubMed ID: 19818381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No association between the PREP gene and lithium responsive bipolar disorder.
    Mamdani F; Sequeira A; Alda M; Grof P; Rouleau G; Turecki G
    BMC Psychiatry; 2007 Feb; 7():9. PubMed ID: 17324276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic influences on response to mood stabilizers in bipolar disorder: current status of knowledge.
    Rybakowski JK
    CNS Drugs; 2013 Mar; 27(3):165-73. PubMed ID: 23378337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome-wide association study identifies SESTD1 as a novel risk gene for lithium-responsive bipolar disorder.
    Song J; Bergen SE; Di Florio A; Karlsson R; Charney A; Ruderfer DM; Stahl EA; ; Chambert KD; Moran JL; Gordon-Smith K; Forty L; Green EK; Jones I; Jones L; Scolnick EM; Sklar P; Smoller JW; Lichtenstein P; Hultman C; Craddock N; Landén M; Smoller JW; Perlis RH; Lee PH; Castro VM; Hoffnagle AG; Sklar P; Stahl EA; Purcell SM; Ruderfer DM; Charney AW; Roussos P; Michele Pato CP; Medeiros H; Sobel J; Craddock N; Jones I; Forty L; Florio AD; Green E; Jones L; Gordon-Smith K; Landen M; Hultman C; Jureus A; Bergen S; McCarroll S; Moran J; Smoller JW; Chambert K; Belliveau RA
    Mol Psychiatry; 2016 Sep; 21(9):1290-7. PubMed ID: 26503763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No association between lithium full responders and the DRD1, DRD2, DRD3, DAT1, 5-HTTLPR and HTR2A genes in a Sardinian sample.
    Manchia M; Congiu D; Squassina A; Lampus S; Ardau R; Chillotti C; Severino G; Del Zompo M
    Psychiatry Res; 2009 Sep; 169(2):164-6. PubMed ID: 19647327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Pharmacogenomics of Bipolar Disorder study (PGBD): identification of genes for lithium response in a prospective sample.
    Oedegaard KJ; Alda M; Anand A; Andreassen OA; Balaraman Y; Berrettini WH; Bhattacharjee A; Brennand KJ; Burdick KE; Calabrese JR; Calkin CV; Claasen A; Coryell WH; Craig D; DeModena A; Frye M; Gage FH; Gao K; Garnham J; Gershon E; Jakobsen P; Leckband SG; McCarthy MJ; McInnis MG; Maihofer AX; Mertens J; Morken G; Nievergelt CM; Nurnberger J; Pham S; Schoeyen H; Shekhtman T; Shilling PD; Szelinger S; Tarwater B; Yao J; Zandi PP; Kelsoe JR
    BMC Psychiatry; 2016 May; 16():129. PubMed ID: 27150464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A possible association between missense polymorphism of the breakpoint cluster region gene and lithium prophylaxis in bipolar disorder.
    Masui T; Hashimoto R; Kusumi I; Suzuki K; Tanaka T; Nakagawa S; Suzuki T; Iwata N; Ozaki N; Kato T; Takeda M; Kunugi H; Koyama T
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):204-8. PubMed ID: 17822820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is the polarity of relapse/recurrence in bipolar-I disorder patients related to serum lithium levels? Results from an empirical study.
    Severus WE; Kleindienst N; Evoniuk G; Bowden C; Möller HJ; Bohus M; Frangou S; Greil W; Calabrese JR
    J Affect Disord; 2009 Jun; 115(3):466-70. PubMed ID: 19019453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotective effect of lithium on hippocampal volumes in bipolar disorder independent of long-term treatment response.
    Hajek T; Bauer M; Simhandl C; Rybakowski J; O'Donovan C; Pfennig A; König B; Suwalska A; Yucel K; Uher R; Young LT; MacQueen G; Alda M
    Psychol Med; 2014 Feb; 44(3):507-17. PubMed ID: 23721695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A glutamatergic network mediates lithium response in bipolar disorder as defined by epigenome pathway analysis.
    Higgins GA; Allyn-Feuer A; Barbour E; Athey BD
    Pharmacogenomics; 2015; 16(14):1547-63. PubMed ID: 26343379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of lithium treatment response in Sardinian bipolar patients].
    Chillotti C; Deiana V; Manchia M; Lampus SF; Ardau R; Severino G; Del Zompo M
    Riv Psichiatr; 2009; 44(1):28-35. PubMed ID: 20066935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Long-term treatment of bipolar disorder: how should we use lithium salts?].
    Del Grande C; Muti M; Musetti L; Pergentini I; Corsi M; Turri M; Soldani I; Corsini GU; Dell'Osso L
    Riv Psichiatr; 2012; 47(6):515-26. PubMed ID: 23160112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphism of circadian clock genes and prophylactic lithium response.
    Rybakowski JK; Dmitrzak-Weglar M; Kliwicki S; Hauser J
    Bipolar Disord; 2014 Mar; 16(2):151-8. PubMed ID: 24636202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring Genetic Variability at PI, GSK3, HPA, and Glutamatergic Pathways in Lithium Response: Association With IMPA2, INPP1, and GSK3B Genes.
    Mitjans M; Arias B; Jiménez E; Goikolea JM; Sáiz PA; García-Portilla MP; Burón P; Bobes J; Vieta E; Benabarre A
    J Clin Psychopharmacol; 2015 Oct; 35(5):600-4. PubMed ID: 26267417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of excellent response to lithium: results from a nationwide register-based study.
    Kessing LV; Hellmund G; Andersen PK
    Int Clin Psychopharmacol; 2011 Nov; 26(6):323-8. PubMed ID: 21876441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased mRNA expression of peripheral glial cell markers in bipolar disorder: The effect of long-term lithium treatment.
    Ferensztajn-Rochowiak E; Tarnowski M; Samochowiec J; Michalak M; Ratajczak MZ; Rybakowski JK
    Eur Neuropsychopharmacol; 2016 Sep; 26(9):1516-1521. PubMed ID: 27474686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucocorticoid receptor polymorphism is associated with lithium response in bipolar patients.
    Szczepankiewicz A; Rybakowski JK; Suwalska A; Hauser J
    Neuro Endocrinol Lett; 2011; 32(4):545-51. PubMed ID: 21876507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.